Abstract:Objective: To evaluate the middle-term efficacy and complications of ultrasound-guided high intensity focused ultrasound (USgHIFU) for the treatment of symptomatic uterine fibroids in an NHS population. Methods: A prospective observational single-center study at a single university hospital in Oxford, UK. Patients with symptomatic uterine fibroids who declined standard surgical/radiological intervention and were referred to the HIFU unit were considered for USgHIFU treatment. Clinical evaluation, adverse event monitoring, uterine fibroid symptoms and health-related quality of life questionnaire (UFS-QOL) and contrast-enhanced pelvic magnetic resonance imaging (MRI) were performed before and at regular intervals after treatment to assess patient outcome. Results: 12 of 22 referred patients underwent one session of USgHIFU ablation of 14 fibroids overall and received a two-year follow-up. No serious adverse events were reported, but a second-degree skin burn was observed in one patient who had a surgical scar from a previous caesarean section. Mean symptom severity scores (SSS-QOL) improved significantly from 56.5 ± 29.1 (SD) at baseline to 33.4 ± 23.3 (p < 0.01) at three months, 45.0 ± 35.4 (p < 0.05) at one year and 40.6 ± 32.7 (p < 0.01) at two years post-treatment. The mean non-perfused volume ratio was 67.7 ± 39.0 % (SD) in the treated fibroids (n = 14) within three months of treatment. The mean volume reduction rates of the treated fibroids were 23.3 ± 25.5 % (SD) at 3 months post-treatment (p < 0.01, n = 14), 49.3 ± 23.7 % at 12 months (p < 0.05, n = 8), and 51.9 ± 11.1 % at 24 months (p < 0.005, n = 8). Conclusion: This study demonstrates the clinical efficacy of USgHIFU ablation of uterine fibroids and the low risk of complications. We believe that this noninvasive approach may offer an alternative therapy for women with symptomatic uterine fibroids. While HIFU is fast becoming the standard of care for fibroid ablation in other countries, to our knowledge, this study is the first to present clinical experience of US-guided HIFU ablation of symptomatic uterine fibroids in an NHS population. Plain language summary: High intensity focused ultrasound (HIFU) can be used for the noninvasive ablation of symptomatic uterine fibroids, and MR-guided treatment has already gained FDA approval. Ultrasound-guided HIFU has the advantage of offering practicalities in anesthesia and considerable cost-savings over MR-guided treatments. In this prospective study we have demonstrated the middle-term efficacy and favorable safety profile of ultrasound-guided HIFU for the treatment of symptomatic uterine fibroids for the first time in an NHS population.

Early Experience: High-Intensity Focused Ultrasound Treatment for Intra-Abdominal Aggressive Fibromatosis of Failure in Surgery

Clinical Effectiveness and Potential Long-Term Benefits of High-Intensity Focused Ultrasound Therapy for Patients with Adenomyosis.

Effective High Intensity Focused Ultrasound Treatment In Recurrent Aggressive Breast Fibromatosis: A Case Report

Use of a Combination of Acoustic Radiation Force Impulse Imaging(ARFI) and Contrast Enhanced Ultrasonography to Assess The Therapeutic Effect of High Intensity Focused Ultrasound(HIFU) in Hysteromyoma

High-intensity Focused Ultrasound Treatment As an Alternative Regimen for Myxofibrosarcoma.

Superficial Malignant Tumors: Non-invasive Treatment with Ultrasonographically Guided High-Intensity Focused Ultrasound

The Early Therapeutic Effect of Ultrasound Ablation on Uterine Fibroidsin

Five-year follow-up after a single US-guided high intensity focused ultrasound treatment of breast fibroadenoma

Clinical Curative Effect of High Intensity Focused Ultrasound Treatment on Uterine Leiomyoma (report of 135 Cases)

Initial Treatment for Surgery-Naïve Desmoid Tumors by High Intensity Focused Ultrasound

Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience

Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids

500 Cases of High-intensity Focused Ultrasound (HIFU) Ablated Uterine Fibroids and Adenomyosis

The Evaluation of the Efficacy of High Intensity Focused Ultrasound to Treat Uterine Fibroids

Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids

High-intensity focused ultrasound for the treatment of fibroids: A single-center experience in Singapore

US-guided high-intensity focused ultrasound (HIFU) surgery for uterine fibroids：relationship between the therapeutic effects and signal intensity of preexisting T2-weighted MR images

[Ultrasound-Guided Focused Ultrasound Ablation of Intramural, Submucosal and Subserosal Uterine Fibroids: 12-Month Follow-Up Results].

High-intensity focused ultrasound for treatment of advanced malignant tumors located in the walls of chest and abdomen: a preliminary report

Evaluation of HIFU in Treating Advanced Recurrent or Refractory Pelvic Gynecologic Malignant Tumors

High Intensity Focused Ultrasound in the Treatment of Abdominal Malignant Tmnors:Prelaninary Result in 29 Cases